Dicyclomine Hydrochloride Capsules — Class II drug recall D-0733-2026
Ongoing recall by Aurobindo Pharma USA Inc, reported 2026-08-12, distributed nationwide. shortfill; reports of empty capsules.
| Recall number | D-0733-2026 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Aurobindo Pharma USA Inc, East Windsor, NJ, United States |
| Recall initiated | 2026-07-23 |
| Classified | 2026-08-04 |
| Reported by FDA | 2026-08-12 |
| Distributed | Nationwide (US) |
| Quantity | 6,408 bottles |
| NDC | 59651-0719, 59651-0719-01, 59651-0719-99 |
| Lot numbers | DMC125018A |
| Expiration dates | 2027-07 |
Product
Dicyclomine Hydrochloride Capsules, USP, 10mg, 1,000 bottles, Rx only, Distributed by: Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India, NDC 59651-719-99
Reason for recall
shortfill; reports of empty capsules.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0733-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.